Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0000950136-07-006889
Filing Date
2007-10-05
Accepted
2007-10-05 17:18:09
Documents
6

Document Format Files

Seq Description Document Type Size
1 PRELIMINARY MATERIALS file1.htm 424B5 2991078
2 spacer.gif GRAPHIC 43
3 html_300507pblogo.jpg GRAPHIC 27553
4 arrow.gif GRAPHIC 89
5 html_300507linegraph.jpg GRAPHIC 34637
6 html_300507bargraph.jpg GRAPHIC 26945
  Complete submission text file 0000950136-07-006889.txt   3116495
Mailing Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 21000
Business Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 21000 972-4-988-9488
Protalix BioTherapeutics, Inc. (Filer) CIK: 0001006281 (see all company filings)

EIN.: 650643773 | State of Incorp.: FL | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-144801 | Film No.: 071160166
SIC: 2836 Biological Products, (No Diagnostic Substances)